These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 467492

  • 41. Resistance of mouse cytolytic cells to pore-forming protein-mediated cytolysis.
    Shinkai Y, Ishikawa H, Hattori M, Okumura K.
    Eur J Immunol; 1988 Jan; 18(1):29-33. PubMed ID: 3345794
    [Abstract] [Full Text] [Related]

  • 42. Inhibition of experimental tumor metastasis by selective activation of natural killer cells.
    Hanna N.
    Cancer Res; 1982 Apr; 42(4):1337-42. PubMed ID: 6277482
    [Abstract] [Full Text] [Related]

  • 43. Activation of natural killer-derived cytotoxic T lymphocytes. I. Regulation by macrophage and prostaglandins.
    Ting CC, Hargrove ME.
    J Immunol; 1983 Oct; 131(4):1734-41. PubMed ID: 6604751
    [Abstract] [Full Text] [Related]

  • 44. Differential expression of tumor target binding and cytolytic activities in bone marrow culture-derived macrophages.
    Lee KC, La Posta VJ.
    J Natl Cancer Inst; 1986 Dec; 77(6):1287-97. PubMed ID: 3467118
    [Abstract] [Full Text] [Related]

  • 45. Induction of murine lymphokine-activated killer-like cells by Corynebacterium parvum (C. parvum) in vitro: lysis of tumor cells and macrophages by C. parvum-induced killer cells.
    Chen MF, Suzuki H, Yano S.
    Anticancer Res; 1992 Dec; 12(2):451-6. PubMed ID: 1580562
    [Abstract] [Full Text] [Related]

  • 46. The chemiluminescence response of human natural killer cells. II. Association of a decreased response with low natural killer activity.
    Werkmeister J, Helfand S, Roder J, Pross H.
    Eur J Immunol; 1983 Jun; 13(6):514-20. PubMed ID: 6574914
    [Abstract] [Full Text] [Related]

  • 47. Antibody-dependent cellular cytotoxicity against tumor cells. II. The promonocyte identified as effector cell.
    Domzig W, Lohmann-Matthes ML.
    Eur J Immunol; 1979 Apr; 9(4):267-72. PubMed ID: 467490
    [Abstract] [Full Text] [Related]

  • 48. Antibody-dependent cellular cytotoxicity against tumor cells. I. Cultivated bone marrow-derived macrophages kill tumor targets.
    Lohmann-Matthes ML, Domzig W, Taskov H.
    Eur J Immunol; 1979 Apr; 9(4):261-6. PubMed ID: 467489
    [Abstract] [Full Text] [Related]

  • 49. Solid tumor-derived target cell susceptibility to macrophages and natural killer/natural cytotoxic cells in the rat.
    Zöller M, Matzku S.
    Immunobiology; 1983 May; 164(5):349-60. PubMed ID: 6603412
    [Abstract] [Full Text] [Related]

  • 50. Killer-cell lines derived from mouse thymus, resembling large granular lymphocytes and expressing natural killer-like cytotoxicity.
    Born W, Ben-Nun A, Bamberger U, Nakayama M, Speth V, Sun D, Thornton M.
    Immunobiology; 1983 Jul; 165(1):63-77. PubMed ID: 6885103
    [Abstract] [Full Text] [Related]

  • 51. Strain differences in natural killer cell-mediated immunity among mice: a possible mechanism for the low natural killer cell activity of A/J mice.
    Whyte AL, Miller SC.
    Immunobiology; 1998 Jul; 199(1):23-38. PubMed ID: 9717665
    [Abstract] [Full Text] [Related]

  • 52. Malaria infections in different strains of mice and their correlation with natural killer activity.
    Eugui EM, Allison AC.
    Bull World Health Organ; 1979 Jul; 57 Suppl 1(Suppl):231-8. PubMed ID: 317441
    [Abstract] [Full Text] [Related]

  • 53. Studies on the activation of mouse bone marrow-derived macrophages by the macrophage cytotoxicity factor (MCF).
    Meerpohl HG, Lohmann-Matthes ML, Fischer H.
    Eur J Immunol; 1976 Mar; 6(3):213-7. PubMed ID: 1086777
    [Abstract] [Full Text] [Related]

  • 54. Induction of natural killer cells by herpes-simplex virus type 2 in resistant and sensitive inbred mouse strains.
    Armerding D, Rossiter H.
    Immunobiology; 1981 Mar; 158(4):369-79. PubMed ID: 6263793
    [Abstract] [Full Text] [Related]

  • 55. Suppressive effects of 3-methylcholanthrene on the in vitro antitumor activity of naturally cytotoxic cells.
    Lill PH, Gangemi JD.
    J Toxicol Environ Health; 1986 Mar; 17(4):347-56. PubMed ID: 3959116
    [Abstract] [Full Text] [Related]

  • 56. Variation of interferon induction at the bone marrow level. Studies on interferon induction in relation to natural cell-mediated cytotoxic mechanisms.
    Orn A, Gidlund M, Wigzell H, Gresser I.
    Eur J Immunol; 1981 Oct; 11(10):795-9. PubMed ID: 6171433
    [Abstract] [Full Text] [Related]

  • 57. Variation in selectivity of tumor cell cytolysis by murine macrophages, macrophage-like cell lines and NK cells.
    Wiltrout RH, Brunda MJ, Holden HT.
    Int J Cancer; 1982 Sep 15; 30(3):335-42. PubMed ID: 6813271
    [Abstract] [Full Text] [Related]

  • 58. Functionally different subpopulations of mouse macrophages recognized by monoclonal antibodies.
    Sun D, Lohmann-Matthes ML.
    Eur J Immunol; 1982 Feb 15; 12(2):134-40. PubMed ID: 6978817
    [Abstract] [Full Text] [Related]

  • 59. Macrophage activation for tumor cytotoxicity: genetic variation in macrophage tumoricidal capacity among mouse strains.
    Boraschi D, Meltzer MS.
    Cell Immunol; 1979 Jun 15; 45(1):188-94. PubMed ID: 378423
    [No Abstract] [Full Text] [Related]

  • 60. The inhibitory effect of phenothiazines on NK-mediated cytolysis of tumor cells.
    Laing LP, Boegman RJ, Roder JC.
    Immunopharmacology; 1984 Aug 15; 8(1):1-12. PubMed ID: 6490356
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.